Takes about 2 minutes No cost No obligation
What Is the Bard PowerPort?
The Bard PowerPort is an implantable port catheter device designed to deliver medications, fluids, or chemotherapy directly into a patient’s bloodstream. Inserted under the skin, typically in the chest, it connects to a vein for easy access during treatments, commonly for cancer patients. Introduced by C.R. Bard (now part of Becton Dickinson), the PowerPort uses a polyurethane tube mixed with barium sulfate for X-ray visibility. However, lawsuits claim design flaws, including weak materials prone to cracking, fracturing, or migrating, lead to dangerous complications like infections, blood clots, and organ damage. If you believe you experienced complications related to a Bard PowerPort device, you may request a free case review through our secure intake process.
At Direct2Attorney, we believe in your right to justice.
Complete the secure form with details about your Bard PowerPort device and your experience.
Our intake team reviews your submission to determine whether it may meet the initial screening criteria.
If appropriate, your information may be shared with a participating law firm for an independent review. Direct2Attorney does not provide legal advice or legal representation.
There is no established link between the Bard PowerPort and cancer causation; rather, the device is often used in cancer patients for chemotherapy delivery. Lawsuits focus on other serious health risks caused by defective PowerPorts, such as catheter fractures, migration, and infections. A 2023 lawsuit highlighted how degraded barium sulfate creates cracks where bacteria can grow, causing life-threatening infections, especially in immunocompromised patients. Fractures can lead to pieces migrating to the heart or lungs, requiring emergency surgery, as seen in a case where a Kansas woman’s PowerPort broke during chemotherapy. These complications add significant physical and emotional burdens to already vulnerable patients.
If you’ve experienced complications due to the Bard PowerPort device, we are here to help you request a free case review from participating law firms. Contact Us
Bard PowerPort Lawsuit Updates
As of April 2025, the Bard PowerPort multidistrict litigation (MDL 3081) in Arizona includes hundreds of cases, with new filings added monthly. A key deadline looms: by April 28, 2025, both sides must submit six lawsuits each for bellwether trials, set to begin in 2026, to guide potential settlements. Recent cases include a Kansas woman who suffered a hematoma and fever from a fractured PowerPort and an Iowa plaintiff requiring emergency surgery after catheter fragments reached her heart., Settlement talks are ongoing, with potential payouts estimated at $50,000–$500,000 for severe cases. Direct2attorney is actively accepting cases, urging victims to act before state statutes of limitations expire.
Individuals have filed lawsuits alleging that certain Bard PowerPort devices may have experienced issues such as fractures, migration, infections, or other complications. People who believe they were affected may request a free case review.
Eligibility depends on your medical history, the type of Bard PowerPort device, and the complications you experienced. A participating law firm may independently evaluate your information.
No. Requesting a preliminary case review is free and does not require you to hire a lawyer.
Your information is reviewed through our intake process. If appropriate, it may be shared with a participating law firm for an independent evaluation.
No. Submitting your information does not create an attorney-client relationship. Representation may only begin if a participating law firm agrees to represent you.
Possibly. If additional information is needed during the review process, a participating law firm may request relevant medical records.
We take reasonable steps to protect your information. Your submission is handled according to our Privacy Policy and applicable disclosures.
Review times vary depending on the information provided and the availability of participating law firms.